VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 1342711
Sex: M
Age: 0
State: IL

Vax Date: 02/11/2021
Onset Date: 02/11/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies: Penicillin; Bactrim

Symptoms: Vitals Stable. BP 150/89 / BP 150/89 / BP147/88 HR 70 / HR 64 / HR 64 RR 16 / RR 16 / RR 16.

Other Meds: Metoprolol; Aspirin

Current Illness: None

ID: 1342712
Sex: F
Age: 48
State: KY

Vax Date: 02/17/2021
Onset Date: 02/27/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies: Allergies to Cats, tree, grass

Symptoms: Rash, itchy, red, Rt arm. started 10 days after vaccine (Feb 27th) - Still spreading.

Other Meds: Xyzal 5mg, Prilosec 40mg, Vit D,

Current Illness: NO

ID: 1342714
Sex: F
Age: 65
State: FL

Vax Date: 02/17/2021
Onset Date: 02/25/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data: N/A

Allergies: Vancomycin

Symptoms: Bell's Palsy Faxed on: 3/1/21 by: CMS

Other Meds: Diclofeucle 75 mg bid

Current Illness: NONE

ID: 1342715
Sex: U
Age: 38
State: IL

Vax Date: 02/19/2021
Onset Date:
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Small amount of vaccine leaked between syringe and needle. less than 1/2 the dose. only a drop or two fell out.

Other Meds:

Current Illness: Diabets type II, obesity

ID: 1342716
Sex: F
Age: 39
State: IL

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies: None

Symptoms: Complained of racing heart. Rested. Drank water. Paced outside of car. Complained of numbness in thumbs. Fully alerted and verbal. VS WNL. Escorted patient to restroom. Patient s/s residual.

Other Meds: Albuterol

Current Illness: Asthma

ID: 1342717
Sex: F
Age: 38
State: IL

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies: PCN, clyndomycin, seasonal allergies

Symptoms: Sweling lightheaded about 15 minutes after vaccination, Denies any other symptoms No swelling, hives, or respiratory symptoms noted. Patient calm, speaking very unfiltered, Dr. interviewed patient. She observed Lightheadedness observed additional 15 min & reported sx improved before driving away.

Other Meds: 0

Current Illness: 0

ID: 1399398
Sex: F
Age: 78
State: FL

Vax Date: 02/02/2021
Onset Date: 02/03/2021
Rec V Date: 03/02/2021
Hospital:

Lab Data:

Allergies: Penicillin

Symptoms: Very painful and large swelling and red discoloration around vaccination site on the left arm. Swelling lasted about 10 days. Discoloration is still present

Other Meds: Atenolol 25 mg, Citracal, Vit. C, Red Rice Yeast + Co-Q10

Current Illness: none

ID: 1067888
Sex: F
Age:
State: PR

Vax Date: 01/27/2021
Onset Date: 01/28/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data:

Allergies:

Symptoms: I've had too much stomach upset; Severe heartburn; Persistent mouth dryness; The taste in my mouth changed; Extreme fatigue; This is a spontaneous report from contactable healthcare professional. A 35-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date unspecified), via an unspecified route of administration on 27Jan2021 09:15 at single dose (left arm) for COVID-19 immunization. The patient medical history was not reported. The patient had no known allergies. The patient was not pregnant. There were no concomitant medications. The patient had no other vaccine in other 4 weeks. On 28Jan2021, at 12:00, the patient experienced too much stomach upset, severe heartburn, persistent mouth dryness, the taste in mouth changed and extreme fatigue. The patient received therapy for the events included household medication and natural treatment. The patient did not have covid prior vaccination and was not covid tested post vaccination. Outcome of events was not recovered. Information on the batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 1067889
Sex: U
Age:
State: PR

Vax Date:
Onset Date:
Rec V Date: 03/03/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fatigue; muscle aches; headache; This is a spontaneous report from a contactable consumer (the patient). A patient of an unspecified age and gender received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number not provided), via an unspecified route of administration on an unspecified date (age at vaccination unknown) as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number not provided), via an unspecified route of administration on an unspecified date (age at vaccination unknown) as a single dose for COVID-19 immunization. On an unspecified date after the second dose, the patient experienced fatigue, muscle aches, and headache. The clinical outcome of fatigue, muscle aches, and headache was unknown. No follow-up attempts are possible; information about batch/lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 1067933
Sex: M
Age:
State: MD

Vax Date: 01/30/2021
Onset Date: 01/30/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data: Test Date: 20210131; Test Name: fever; Result Unstructured Data: Test Result:103; Comments: degree; Test Date: 202101; Test Name: COVID; Test Result: Positive ; Comments: Had tested positive asymptomatically for covid due to contact contamination on 02Jan2021 or 03Jan2021

Allergies:

Symptoms: 103 degree fever; chills; body aches; headache; feeling hot through the night; Got sick; This is a spontaneous report from a contactable consumer (the patient). A 58-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number not provided, expiry date May2021), via an unspecified route of administration in the left arm on 30Jan2021 10:00 (at the age of 58-years-old) as a single dose for COVID-19 immunization; and apixaban (ELIQUIS, lot number ABA8272S, NDC 0003089421, expiry date Oct2021) film-coated tablet, via an unspecified route of administration from an unspecified date to 31Jan2021 at 5 mg, twice daily for cerebrovascular accident prophylaxis. Medical history included: he had tested positive asymptomatically for COVID due to contact contamination on 02Jan2021 or 03Jan2021, blood pressure, and A-fib (atrial fibrillation). Concomitant medication included ongoing metoprolol for blood pressure. There were no vaccines administered on same date with the Pfizer vaccine. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient stated that he got sick after getting the vaccine (on 30Jan2021) and had an important question. He got a fever (31Jan2021) and all that stuff that lasted like a day and a half after getting the vaccine, just like a million other people. But he missed the part about asking a doctor about taking his blood thinner, which he took as normal up through the day that he got the vaccine and the next morning, then he stopped it. The patient clarified that he got the vaccine on Saturday (30Jan2021), stopped the blood thinner on Sunday (31Jan2021), the sickness subsided around Monday (as reported), but he still hasn't gone back on the blood thinner. He wanted to know when it was safe for him to start taking the blood thinner again, and he needed to know what to do for the second vaccine. The clinical course was as follows: He got the first dose of the vaccine on 30Jan2021 at 10:00 and at 22:00 he started feeling hot through the night. On Sunday, 31Jan2021, he had 103 degree fever, chills, body aches, and a headache. He clarified that he recovered completely by Wednesday, 03Feb2021. He had been on Eliquis for years for A-Fib. He stopped taking it once he got sick after getting the vaccine and went back and read the material and noticed what it said about the blood thinner. He did not go to the emergency room or physician's office. The action taken in response to the events for apixaban was temporarily withdrawn. The outcome of the events was recovered on 03Feb2021. Follow-up (05Feb2021): This is a spontaneous report from a contactable consumer based on information received by Pfizer from Bristol-Myers Squibb (manufacturer control number US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013684), license party for apixaban (ELIQUIS). This case was received via Pfizer Inc (Reference number: #) on 05Feb2021 and was forwarded to BMS on 09Feb2021. This spontaneous case was reported by a patient and describes the occurrence of PYREXIA (103 degree fever), CHILLS, PAIN (bodyaches) and HEADACHE in 58-year-old male patient who received apixaban (Eliquis) film-coated tablet (batch no. ABA8272S) for Cerebrovascular accident prophylaxis. CO-SUSPECT PRODUCTS included Covid-19 Vaccine injection for COVID-19 immunisation. Concurrent medical conditions included Blood pressure abnormal. On an unknown date, the patient started Eliquis (batch no. ABA8272S) (unknown route), 5 milligram twice a day. On 30Jan2021, the patient started Covid-19 Vaccine (unknown route) Unknown dose by injection in left arm. On 31Jan2021, an unknown time after starting Eliquis, the patient experienced PYREXIA (103 degree fever), CHILLS, PAIN (bodyaches) and HEADACHE. Eliquis (Unknown) was interrupted due to event. On 03Feb2021, PYREXIA, CHILLS, PAIN and HEADACHE resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31Jan2021, Body temperature: 103 degree. For Eliquis (Unknown), the reporter did not provide any causality assessments. Information about lot/batch number has been requested.

Other Meds: METOPROLOL

Current Illness:

ID: 1067934
Sex: M
Age:
State: FL

Vax Date: 11/01/2020
Onset Date: 02/14/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data: Test Name: weight; Result Unstructured Data: Test Result:approximately between 185-190

Allergies:

Symptoms: Dizziness; This is a spontaneous report from a contactable consumer, based on information received by Pfizer from Bristol-Myers Squibb (manufacturer control number: US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-016013), license party for apixaban (ELIQUIS). This case was received via Pfizer Inc (Reference number: 2021162914) on 15-Feb-2021 and was forwarded to BMS on 16-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of dizziness in 65-year-old male patient who received apixaban (ELIQUIS) for venous thromboembolism. Co-suspect products included covid-19 vaccine for covid-19 immunisation. Patient weight was reported as approximately between 185-190 (Units not specified). The patient's past medical history included Open heart surgery (had two open heart surgeries. Believes first one was 2002 or 2004, second was 5 years ago, sometime in 2016) and COVID-19 in November 2020. Concurrent medical conditions included Diabetes and Coronary artery disease in 2002. In November 2020, the patient started ELIQUIS (unknown route), 5 milligrams twice a day. On 14-Feb-2021, the patient started covid-19 vaccine (unknown route). On the same day, the patient experienced dizziness. The dose of ELIQUIS (unknown) was not changed. At the time of the report, dizziness did not resolve. For ELIQUIS (unknown), the reporter did not provide any causality assessments. About three hours after getting covid shot patient felt dizziness. It was like he was disoriented or something. It was like his equilibrium was off. He was off balance with it. He is not 100 percent balanced. Patient got Flu Shot, Pneumonia shot previously. No prior vaccinations within 4 weeks. Further follow up was not performed, as sufficient data reported. Causality Assessment: Drug: ELIQUIS Dizziness Per Reporter = No Information Per Company (Bristol-Myers Squibb) = Related

Other Meds: ENTRESTO; RANOLAZINE EXTENDED RELEASE; DIGOXIN; ROSUVASTATIN; CLOPIDOGREL; ISOSORBIDE; PREGABALIN; AMLODIPINE; METOPROLOL; FENOFIBRATE; PANTOPRAZOLE; GLIPIZIDE; METFORMIN HYDROCHLORIDE; ROPINIROLE HYDROCHLORIDE; FUROSEMIDE; ACETAMINOPHEN AN

Current Illness: Coronary artery disease; Diabetes

ID: 1067935
Sex: F
Age:
State: MA

Vax Date: 01/30/2021
Onset Date:
Rec V Date: 03/03/2021
Hospital:

Lab Data:

Allergies:

Symptoms: increased need for oxygen; difficulty breathing; A spontaneous report was received from a consumer concerning a 85 year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events needing additional oxygen (PT: Hypoxia) and difficulty breathing (PT: Dyspnoea). The patient's medical history was not provided. No relevant concomitant medications were reported. On 30 Jan 21, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 intramuscularly for the COVID-19 infection prophylaxis. On an unknown date, the patient experienced increase difficulty breathing and increased need for oxygen. Treatment included oxygen. Action taken with mRNA-1273 in response to the events was not reported. The outcome of the events, needing additional oxygen and difficulty breathing, were unknown/not reported.; Reporter's Comments: This case concerns an 85-year-old female who experienced a serious unexpected event of HYPOXIA along with a nonserious unexpected event of DYSPNOEA. The events occurred with unknown latency after the first dose of mRNA-1273. Treatment not reported. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1067936
Sex: M
Age:
State: OH

Vax Date: 02/11/2021
Onset Date:
Rec V Date: 03/03/2021
Hospital: Y

Lab Data:

Allergies:

Symptoms: acute adrenal crisis; A spontaneous report was received from a Physician regarding his son who received second dose of Moderna Covid-19 vaccine and have experienced acute adrenal crisis. The patient's medical history was not provided. His concomitant medications were not provided. No information on allergies. On 11-FEB-2021, prior to the onset of events, the patient received second of two planned doses of Covid-19 vaccine for the prophylaxis of Covid-19 infection. Patient lives in a group home. On an unspecified date, he seemed to be confused, disoriented and unable to talk. Father met him at Emergency department where the patient had an acute adrenal crisis , and after ruling out stroke ,he was diagnosed with Addison's disease(loss of adrenal function). He was admitted and discharged after two days. Post discharge, he seemed totally normal. Action taken with the vaccine is not applicable as the patient received both the doses. The outcome of the event acute adrenal crisis is considered recovered at the time of report.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Further information has been requested.

Other Meds:

Current Illness:

ID: 1067937
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 03/03/2021
Hospital: Y

Lab Data:

Allergies:

Symptoms: Sepsis; A spontaneous report was received from a consumer of unknown age and gender, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced sepsis. The patient's medical history was not provided. Concomitant product use was not provided by the reporter. On an unknown date, the patient received a dose (first or second dose not specified) of mRNA-1273 (Batch number not provided) for prophylaxis of COVID-19 infection. On an unknown date, the patient was reportedly rushed to the hospital for sepsis (details not provided). Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not reported. The outcome of the event, sepsis was not reported.; Reporter's Comments: Very limited information regarding the events has been provided at this time and is insufficient for causality assessment.

Other Meds:

Current Illness:

ID: 1067938
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 03/03/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Developed PMR; negative effect; A spontaneous report was received from a consumer concerning a patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events( vaccination complication i.e., polymyalgia rheumatica) list. The patient's medical history was not provided. No relevant concomitant medications were reported. on unknown date, prior to the onset of the events, the patient received mRNA vaccine for prophylaxis of COVID-19 infection. on unknown date, the patient experienced the events list (polymyalgia rheumatica) with seriousness criteria. Laboratory details are not provided. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The outcome of the event was not reported.; Reporter's Comments: Very limited information regarding these events has been provided at this time. Further information has been requested.

Other Meds:

Current Illness:

ID: 1067939
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 03/03/2021
Hospital:

Lab Data:

Allergies:

Symptoms: bloody stools; A spontaneous report was received from an unknown reporter concerning a male patient, who received Moderna's COVID-19 vaccine (mRNA-1273), experienced bloody stools for 2 days. The patient's medical history was not provided. Concomitant product use was not provided/unknown by the reporter. On 05-JAN-2021, the patient received their first of two planned doses of mRNA-1273 (Batch number: 025L20A) for prophylaxis of COVID-19 infection. Patient reported to the nurse at his second Moderna vaccine appointment that he had bloody stools for 2 days, and then the bloody stools stopped. Treatment information was not provided/unknown. Action taken with mRNA-1273 in response to the event(s) was not provided/unknown. The event, blood stools for 2 days , was recovered/resolved on an unknown date.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Further information has been requested.

Other Meds:

Current Illness:

ID: 1067940
Sex: F
Age: 68
State: MI

Vax Date: 02/12/2021
Onset Date: 02/13/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Passed out and fell on the bathroom floor; didn't feel well; Passed out and fell on the bathroom floor; Nauseated; Arm was sore; A spontaneous report was received from a consumer concerning a 68-years-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) experienced arm was sore, nauseated, didn't feel well, passed out and fell on the bathroom floor. The patient's medical history was not provided. Concomitant product use was not provided by the reporter. On 12 Feb 2021, approximately one day prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number not provided) intramuscularly in the left arm for prophylaxis of COVID-19 infection. On 13 Feb 2021, the patient experienced sore arm, not feeling well, nausea, passed out and fell on the bathroom floor. Treatment information was not provided. Action taken with mRNA-1273 in response to the events was not provided. The outcome of the events arm was sore, nauseated, didn't feel well, passed out and fell on the bathroom floor were unknown.; Reporter's Comments: This case concerns a 68-year-old female who experienced serious unexpected events of Loss of consciousness, along with nonserious unexpected malaise and fall and NS expected vaccination site pain and nausea. The events occurred 2 days after the first dose of mRNA-1273. Treatment not reported. Event outcome unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1067941
Sex: F
Age:
State: CT

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Blood pressure 170/120; Fast heart rate; Rash on her arm that spread across her body, rash felt itchy and hot; Rash felt itchy and hot; Headache; A spontaneous report was received from a consumer concerning, a 48-years-old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced fast heart rate, BP:170/120, rash spread from arm to her body, rash felt hot and headache. The patient's medical history was not provided. No relevant concomitant medications were reported. On 22 Jan 2021, 1 day prior to onset of the events fast heart rate, BP:170/120, rash spread from arm to her body, rash felt hot and headache, patient received their dose of mRNA-1273 (lot/batch: 029L420A) intramuscularly for prophylaxis of COVID-19 infection. On 22 Jan 2021, the patient had medically significant events of increased heart rate, BP:170/120, rash spread from arm to her body, rash felt itchy and hot and non serious event of headache. The patient stayed at the ER (emergency room) for 3 hours. Treatment included diphenhydramine. Action taken with mRNA-1273 in response to the events was not reported. The outcome of events increased heart rate, BP:170/120, rash spread from arm to her body, rash felt itchy and hot was recovered on 22 Jan 2021. The outcome of the event headache was not recovered.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1067942
Sex: M
Age: 84
State: MD

Vax Date: 02/04/2021
Onset Date: 02/05/2021
Rec V Date: 03/03/2021
Hospital: Y

Lab Data:

Allergies:

Symptoms: Stroke; A spontaneous report was received from a Consumer and Other HCP concerning a 84Years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced event like Stroke. The patient's medical history provided no adverse event. Relevant concomitant medications were reported like atorvastatin calcium, ezetimibe, niacin, metoprolol, acetylsalicylic acid, levothyroxine sodium, and iron supplement. On 4th Feb 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 038k20a) intramuscularly in the left arm for prophylaxis of COVID-19 infection. On date 5th Feb 2021, The patient experienced the event like Stroke, which required hospitalization. It was noted the patient's speech was getting better, but the left side of his body was still paralyzed. There was no treatment information provided There were no laboratory details provided. Action taken with mRNA-1273 in response to the events was not reported. The outcome of the event is unknown.; Reporter's Comments: Although a temporal association exit, provided information is not adequate to assess the causal association between the event and mRNA-1273. Critical details such as the medical history and diagnostic report is lacking. Causality is also confounded by the patient's advanced age and suspected cardiac related condition (patient is on antihypertensive noted in conmed)

Other Meds: STATIN EZ; NIACIN; METOPROLOL; ASPIRIN (E.C.); SYNTHROID; IRON SUPPLEMENT

Current Illness:

ID: 1067943
Sex: M
Age: 90
State: NC

Vax Date: 01/23/2021
Onset Date: 02/04/2021
Rec V Date: 03/03/2021
Hospital: Y

Lab Data: Test Date: 20210204; Test Name: Blood pressure; Result Unstructured Data: 94/34 mmHg; Test Date: 20210204; Test Name: Body temperature; Result Unstructured Data: 101 Fahrenheit

Allergies:

Symptoms: Blood pressure dropped to 94/34; Covid related pneumonia; Covid-19; A spontaneous report was received from a consumer concerning 90 year-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced the events, blood pressure dropped to 94/34 (hypotension), COVID-19 (Covid-19), and COVID related pneumonia (COVID-19 pneumonia). The patient's medical history was not provided. No relevant concomitant medications were reported. On 23-Jan-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 032L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection. On 04-Feb-2021, the patient experienced the events, blood pressure dropped to 94/34 (hypotension), body temperature was 101.0 0F (Fever), COVID-19 (Covid-19), and COVID related pneumonia (COVID-19 pneumonia).The patient was hospitalized on the same day (04-Feb-2021) and discharged on 12-Feb-2021 post treatment. Blood pressure dropped to 94/34 mmHg and body temperature was 101.0 0F during hospital admission on 04-Feb-2021. Treatment for the event included remdesivir, ceftriaxone, azithromycin, and oxygen therapy. Action taken with mRNA-1273 in response to the events was not reported. At the time of this report, the outcome of the events, blood pressure dropped to 94/34, COVID-19, and COVID related pneumonia, were considered resolved on 12-Feb-2021.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1067944
Sex: F
Age:
State: OR

Vax Date: 01/07/2021
Onset Date: 01/09/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data: Test Date: 20210130; Test Name: COVID-19 test Nasal Swab; Result Unstructured Data: Test Result:Unknown results

Allergies:

Symptoms: Swollen and painful lymph nodes in the left arm where the shot was received.; Swollen and painful lymph nodes in the left arm where the shot was received.; This is a spontaneous report from a contactable healthcare professional (patient). A 20-year-old female patient started received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not reported), via an unspecified route of administration at the left arm on 07Jan2021 12:30 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. The patient experienced swollen and painful lymph nodes in the left arm where the shot was received on 09Jan2021 13:00. Happened after the first dose and the second dose and have not left. The patient did not received any treatment for the events. The patient underwent lab tests and procedures which included COVID-19 test Nasal Swab: unknown results on 30Jan2021. The outcome of the events was not recovered. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1067945
Sex: F
Age:
State:

Vax Date: 01/06/2021
Onset Date: 01/07/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Hives all over my body; Severe abdominal pain; This is a spontaneous report from a contactable other healthcare professional (patient). A 35-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, lot/batch number and expiry date unknown), intramuscular on 06Jan2021 13:00 at a single dose for COVID-19 immunization. The patient's medical history was reported as none. The patient's concomitant medications were not reported. The patient experienced hives all over her body and severe abdominal pain on 07Jan2021. The patient received treatment for the events. The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination. The patient was not pregnant at the time of vaccination. The outcome of the events were recovered on an unspecified date. The events were reported as non-serious. No seriousness criteria provided. The facility where the most recent COVID-19 vaccine was administered was in the hospital. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1067946
Sex: M
Age:
State: CA

Vax Date: 01/09/2021
Onset Date: 01/30/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data:

Allergies:

Symptoms: injection site soreness; This is a spontaneous report from a contactable consumer (Patient). A 44-year-old (also age at vaccination) male patient receive the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL1283), via an unspecified route of administration at the left arm on 09Jan2021 (reported as 29Jan2021; pending clarification) 08:30 at SINGLE DOSE for covid-19 immunization. Medical history included that prior to vaccination the patient was diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had no allergies to medications, food, or other products. The patient was vaccinated at a workplace clinic. The patient's concomitant medications were not reported. It was reported that the patient experienced injection site soreness on 30Jan2021 (as reported date: pending clarification). The outcome of the event was recovering. The treatment received is Diclofenac 100mg. Case was not considered serious (for any criteria).

Other Meds:

Current Illness:

ID: 1067947
Sex: F
Age:
State: MO

Vax Date: 01/28/2021
Onset Date: 01/29/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: Body temperature; Result Unstructured Data: Test Result:102.7 Fahrenheit; Comments: Fever up to 102.7 F lasting from 0500 on 1/29 to 0100 on 1/30. Took 3 doses of 1000 mg Tylenol during this time period which would bring temp down to high 100s for an hour or two. After 0100 on 1/30 had low grade temp in low-mid 100s until the afternoon.

Allergies:

Symptoms: Significant swelling in left axillary lymph node; fever up to 102.7 F/low grade temp in low-mid 100s; Severe chills; fatigue; Moderate muscle aches; This is a spontaneous report from a contactable nurse (patient). A 28-year-old female patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: EL3248, expiry date unknown) in the hospital, via an unspecified route of administration on 28Jan2021 at 15:00 on the left arm at a single dose for COVID-19 immunization. Medical history included allergies to penicillin and sulfa drugs. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included ethinylestradiol, norgestimate (ESTARYLLA) for birth control. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received the first dose of BNT162B2 (lot number: EL1284, expiry date unknown) on 06Jan2021 at 12:00 PM on the left arm for COVID-19 immunization. Since the vaccination, the patient has not been tested for COVID-19. It was reported that the patient experienced fever up to 102.7 F lasting from 05:00 on 29Jan2021 to 01:00 on 30Jan2021. The patient took 3 doses of 1000 mg Tylenol during this time period which would bring temp down to high 100s for an hour or two. After 01:00 on 30Jan2021, the patient had low grade temp in low-mid 100s until the afternoon. The patient also experienced severe chills, fatigue, moderate muscle aches on 29Jan2021 at 05:00. The patient had significant swelling in left axillary lymph node starting on the evening of 30Jan2021. The patient received treatment for the event fever but did not receive treatment for the other events. The outcome of the events was recovering. The events were reported as non-serious.

Other Meds: ESTARYLLA

Current Illness:

ID: 1067948
Sex: M
Age:
State: CA

Vax Date: 01/24/2021
Onset Date: 01/26/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Moderate allergic reaction; itchy skin; itchy eyes; Headache; This is a spontaneous report from a contactable consumer. An 80-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL 9263), via an unspecified route of administration in right arm on 24Jan2021 11:45 at a single dose for COVID-19 immunization. Medical history included Diabetes2, HiBloodPress and HiCholesterol. Concomitant medication included lisinopril, simvastatin, and unspecified diabetes medication. On 26Jan2021, the patient experienced moderate allergic reaction, itchy skin, itchy eyes and headache. The patient was taking antihistamines with some relief for moderate allergic reaction, itchy skin, itchy eyes. There was no treatment for headache. The outcome of the events was recovering. Prior and since the vaccination, the patient was not tested for COVID-19. The events were assessed as non-serious.

Other Meds: LISINOPRIL; SIMVASTATIN

Current Illness:

ID: 1067949
Sex: F
Age:
State: MI

Vax Date: 01/18/2021
Onset Date: 01/19/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data: Test Date: 20210119; Test Name: fever; Result Unstructured Data: Test Result:101.3

Allergies:

Symptoms: Injection site pain; Fever of 101.3; Tired; Headache; This is a spontaneous report from a contactable consumer (patient). A 56-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3248, expiry date: unknown), via an unspecified route of administration on 18Jan2021 20:00 (at the age of 56 years old), at a single dose in the left arm for covid-19 immunisation. Medical history included allergies: dust, mold, trees & grass; and diagnosed with covid-19 on unspecified date. Concomitant medications included escitalopram oxalate (LEXAPRO) and fexofenadine hydrochloride (ALLEGRA 24 HOUR). The patient previously took augmentin and experienced allergies. The patient is not pregnant at the time of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient has not been tested for covid-19 since the vaccination. On 19Jan2021 20:00, the patient experienced injection site pain for seven days and fever of 101.3 which lasted for 12 hours; tired and had a headache for two days. The patient did not receive any treatment for all the events. Outcome of all the events was recovered on unspecified date. The events were reported as non-serious.

Other Meds: LEXAPRO; ALLEGRA 24 HOUR

Current Illness:

ID: 1067950
Sex: F
Age:
State: SC

Vax Date: 01/27/2021
Onset Date: 01/28/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data: Test Name: blood work; Result Unstructured Data: Test Result:Unknown results

Allergies:

Symptoms: she experienced dizziness and weakness; she experienced dizziness and weakness; This is a spontaneous report from a contactable consumer (patient) via the medical information team. A 70-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot: EL9262, expiry: May2021), via an unspecified route of administration (at the age of 70years) on 27Jan2021 at single dose for covid-19 immunisation. Medical history included hypertension and Crohn's. Concomitant medications included lisinopril, estradiol, levothyroxine and adalimumab (HUMIRA) for Crohn's. The patient received the first dose of the Pfizer-BioNtech Covid-19 vaccine on Wednesday. Next morning (on 28Jan2021) from Thursday until Saturday, she experienced dizziness and weakness as stated, "when I woke I was severely dizzy and just weak and that is continued yesterday, well let's say Thursday, Friday and yesterday. I am feeling better today but I wanted to report that". The patient wanted to know if she should receive the second dose of the vaccine because these two symptoms were reported as signs of a severe allergic reaction and that's a contraindication to receive the second dose of the vaccine. The patient had some blood work done on an unspecified date. The patient took some diphenhydramine hydrochloride (BENADRYL) according to her physician. The patient further stated, "I am just, I guess concerned, it does say on the paperwork that I received that you should not take the second dose if you had a severe allergic reaction which it list the dizziness and weakness one of those included so I am assuming that I should not take the second dose." The patient considered the events as non-serious. The outcome of the events was recovering.

Other Meds: LISINOPRIL; ESTRADIOL; LEVOTHYROXINE; HUMIRA

Current Illness:

ID: 1067951
Sex: M
Age:
State: CA

Vax Date: 01/25/2021
Onset Date: 01/26/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Coughing; loss of taste and smell; loss of taste and smell; This is a spontaneous report from a contactable consumer (reporting for himself). A 42-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Solution for injection (lot number: EL3302, expiration date unknown) via an unspecified route of administration in the left arm on 25Jan2021 (at 42 years old) at a SINGLE DOSE for COVID-19 immunization. The patient received the vaccine at a Hospital, reported as "Military Base." The patient had no medical history and had no allergies to medications, food, or other products. Concomitant medications were not reported. The patient did not receive any other medications within 2 weeks of vaccination. The patient was not diagnosed with COVID prior to vaccination, did not receive any other vaccines within 4 weeks prior to BNT162B2, and has not been tested for COVID since the vaccination. On 26Jan2021, the patient experienced coughing, loss of taste and smell. The adverse events resulted in doctor or other healthcare professional office/clinic visit. It was unknown if patient treatment for the adverse events. Outcome of the events was not recovered. The events were reported as non-serious.

Other Meds:

Current Illness:

ID: 1067952
Sex: F
Age:
State: IL

Vax Date: 12/17/2020
Onset Date: 12/17/2020
Rec V Date: 03/03/2021
Hospital:

Lab Data:

Allergies:

Symptoms: flu-like symptoms; headache; aches; chills; night sweats; more fatigue than normal; This is a spontaneous report from a contactable nurse (patient). A 41-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), via an unspecified route of administration in the left arm on 17Dec2020 16:30 at a single dose for COVID-19 immunization. Medical history included Seizure disorder, depression, anxiety, mild hyperthyroidism and Penicillin allergy. The patient was not diagnosed with COVID-19 prior to the vaccination. The patient is not pregnant at the time of vaccination. Concomitant medication included carbamazepine, citalopram, buspirone hydrochloride (BUSPAR), and omeprazole. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. The patient experienced flu-like symptoms, headache, aches, chills, night sweats, and more fatigue than normal on 17Dec2020 19:00. Treatment was not provided in response to the events. The outcome of the events was recovered on an unspecified date. The reporter assessed the events as non-serious. The patient has not been tested for COVID-19 since the vaccination. Information on the lot/batch number has been requested.

Other Meds: CARBAMAZEPINE; CITALOPRAM; BUSPAR; OMEPRAZOLE

Current Illness:

ID: 1067953
Sex: F
Age:
State: NC

Vax Date: 01/25/2021
Onset Date: 01/25/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data: Test Name: blood pressure; Result Unstructured Data: Test Result:high

Allergies:

Symptoms: I am an asthmatic. Fine until 25 mins. after vaccine then tightness in chest that lasted about 45-60 mins. Next day asthma had started.; I am an asthmatic. Fine until 25 mins. after vaccine then tightness in chest that lasted about 45-60 mins. Next day asthma had started.; This is a spontaneous report from a contactable consumer (patient). A 73-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: LL3248, expiry date not reported), via an unspecified route of administration at the right arm on 25Jan2021 09:00 at single dose for COVID-19 immunization. Medical history included allergies, chronic asthma, immune deficiency, high blood pressure, allergic to injections and infusions. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. Concomitant medications were not reported. On 25Jan2021 09:00, the patient stated that she was an asthmatic. She was fine until 25 mins. After vaccine, she then experienced tightness in chest that lasted about 45-60 mins. On the next day, asthma had started. She had the vaccine on Monday, and called her physician and requested to come to be checked which she did. The patient underwent lab tests and procedures which included blood pressure measurement: high on an unspecified date. Therapeutic measure was taken for the events that included Symbicort inhaler. Clinical outcome of the events was recovering.

Other Meds:

Current Illness:

ID: 1067954
Sex: F
Age:
State: NV

Vax Date: 01/30/2021
Onset Date: 01/31/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fever; Headache; Lightheaded; This is a spontaneous report from a contactable consumer. A 27-year-old female patient received bnt162b2 PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 30Jan2021 09:00 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced Fever, Headache, Lightheaded; all on 31Jan2021 at 05:00 AM. No treatment was received for the events.

Other Meds:

Current Illness:

ID: 1067955
Sex: F
Age:
State: WI

Vax Date: 01/23/2021
Onset Date: 01/25/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Swelling of the lymph nodes (mid neck/clavicle area) in the same arm as the injection.; This is a spontaneous report from a contactable nurse (patient). A 36-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported) (at 36 years of age), via an unspecified route of administration in the left arm on 23Jan2021 10:15 at a single dose for COVID-19 immunization. Medical history included multiple sclerosis (MS) and allergy to nickel. Concomitant medication included interferon beta-1a (AVONEX), buprenorphine hydrochloride, naloxone hydrochloride (SUBOXONE), colecalciferol (VITAMIN D [COLECALCIFEROL]), and bupropion hydrochloride (WELLBUTRIN). The patient previously took REGLAN [metoclopramide] and experienced allergy. Historical vaccine included PFIZER BIONTECH COVID 19 VACCINE first dose (at 36 years of age) on 02JAN2021 08:30 AM via unknown route of administration in the left arm for COVID-19 immunization. The patient was not pregnant. She had not had other vaccine in four weeks prior to covid vaccine. She had no covid prior vaccination and she was not tested for covid post vaccination. The patient experienced swelling of the lymph nodes (mid neck/clavicle area) in the same arm as the injection on 25Jan2021 with outcome of recovering. There was no treatment received for the events. The event resulted to Doctor or other healthcare professional office/clinic visit. Information on the lot/Batch number has been requested.

Other Meds: AVONEX; SUBOXONE; VITAMIN D [COLECALCIFEROL]; WELLBUTRIN

Current Illness:

ID: 1067956
Sex: F
Age:
State: PA

Vax Date: 01/23/2021
Onset Date: 01/31/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data:

Allergies:

Symptoms: left side of neck was very sore; felt a swollen lump /lymph about halfway between my ear and bottom of my neck; This is a spontaneous report from a contactable consumer (Patient). A 48-year-old female patient (also the age at vaccination) received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unknown: Unable to locate or read the details), via an unspecified route of administration at the left arm on 23Jan2021 12:45 PM at SINGLE DOSE for Covid-19 immunization. Medical history included Chiari Malformation (reported as other medical history). The patient has no COVID prior to vaccination, also not COVID tested post vaccination. The patient had no known allergies. The patient is not pregnant. There was no other vaccine in four weeks. It was reported that the patient had other medications in two weeks (unspecified). The patient had the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 02Jan2021 at 12:45 PM at the left arm for COVID-19 immunization (Lot number not reported: Unable to locate or read the details, facility type vaccine: Other). It was reported by the patient that: "I woke up this morning (on 31Jan2021 at 08:00 AM) and my left side of neck was very sore. I went to rub it and immediately felt a swollen lump /lymph about halfway between my ear and bottom of my neck. It is about the size of a dime. My second dose was 8 days ago (23Jan2021). I am assuming this is normal response to Pfizer vaccine, but all I read said reactions should be over 2 to 4 days after vaccine. Is this considered normal or should I contact my PCP? " No treatment was received. The outcome of the events was not recovered. Information about Lot and batch number has been requested.

Other Meds:

Current Illness:

ID: 1067957
Sex: M
Age:
State: TN

Vax Date:
Onset Date:
Rec V Date: 03/03/2021
Hospital:

Lab Data:

Allergies:

Symptoms: sore arm; This is a spontaneous report from a contactable consumer. A 56-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) first dose, lot number and expiration date unknown, via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization and ibuprofen (MOTRIN), via an unspecified route of administration from an unspecified date at 600 mg for an unspecified indication. The patient's medical history and concomitant medications were not reported. The patient took ibuprofen 600mg 1hr before getting 1st dose of vaccine on Wednesday. He only had a sore arm after the 1st dose. The patient read that he should not have taken medication before vaccine. He was asking for information about the vaccine efficacy since he took ibuprofen before the dose. He mentioned that maybe he should stop taking his antihistamine before the next dose. He was most concerned that he messed up the vaccine. The action taken in response to the event for ibuprofen and the outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1067958
Sex: F
Age:
State: WI

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data:

Allergies:

Symptoms: I experienced Abdominal cramping, chills, and diarrhea onset within 3 hours of vaccine administration; I experienced Abdominal cramping, chills, and diarrhea onset within 3 hours of vaccine administration; I experienced Abdominal cramping, chills, and diarrhea onset within 3 hours of vaccine administration; left arm soreness onset evening of vaccine for about 1.5 days; This is a spontaneous report from a contactable nurse (also the patient). A 51-year-old female (also the age at vaccination) patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL3248), via an unspecified route of administration at the left arm on 07Jan2021 14:40 (also reported as 02:45 PM) at SINGLE DOSE for Covid-19 immunization. The patient was vaccinated at a Hospital. The patient is not pregnant at the time of the report. Medical history included Environmental allergies: some trees and grass (also reported as Known allergies: No). The patient had no COVID prior to vaccination. Th patient was not COVID tested post vaccination. No other vaccine in four weeks. Concomitant medication included (reported as Other medications in two weeks) bupropion hydrochloride (WELLBUTRIN), loratadine, pseudoephedrine sulfate (CLARITIN-D), montelukast sodium (SINGULAIR), diphenhydramine hydrochloride (BENADRYL), vitamin d nos (VITAMIN D NOS) and MVM (exact meaning unspecified). It was reported that: "Administration time on my paperwork was documented incorrectly; I received 07Jan2021 dose at 2:40pm and not the 1:40pm time that is documented. I experienced Abdominal cramping, chills, and diarrhea onset within 3 hours of vaccine administration (reported as 5:30 PM), lasting about 2 hours and resolved; left arm soreness onset evening of vaccine for about 1.5 days." The patient was not treated for the events. The outcome of the events was recovered.

Other Meds: WELLBUTRIN; CLARITIN-D; SINGULAIR; BENADRYL; VITAMIN D NOS

Current Illness:

ID: 1067959
Sex: F
Age:
State: NJ

Vax Date: 01/29/2021
Onset Date: 01/29/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data: Test Date: 20210129; Test Name: Heart Rate; Result Unstructured Data: Test Result:115 bpm; Comments: elevated

Allergies:

Symptoms: face started to feel "hot and on fire"; face and neck turned bright red; face started to feel really tight; Heart Rate then was elevated to 115 bpm; shortness of breath; itchy eyes; headache; nausea; Arm still felt sore; fatigued; At site of injection there was a warm sensation; metallic taste in my mouth; This is a spontaneous report from a contactable nurse (patient). A 41-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9262) solution for injection, intramuscular at left arm on 29Jan2021 at 10:30 AM at single dose for COVID-19 immunization. Medical history included asthma. The patient has no known allergies. The patient's concomitant medications were not reported. The patient was not pregnant and has no other vaccines in four weeks. She will have a birth control in two weeks. It was unknown if the patient has COVID prior to vaccination. She was not tested with COVID post vaccination. The patient was given COVID-19 vaccine at a hospital. When she initially received the vaccine on 29Jan2021, the site of injection had a warm sensation which resolved within a minute. Then on the ride home, she had a metallic taste in her mouth. While at home around 4:00 PM, her face started to feel hot and on fire and then her face and neck turned bright red. Her face started to feel really tight and hot. Heart rate was then elevated to 115 bpm. She then started having shortness of breath, itchy eyes, headache and nausea. The patient sat down and took 10 mL of BENEDRYL (as reported) at 4:30 PM or 4:40 PM. Between 5:00 PM and 7:00 PM, her face and neck were still slightly red. Her arm felt sore and she was fatigued. She again took 10 mL of BENEDRYL at 7:30 PM. She woke up on 30Jan2021 and still felt fatigued and the back of arm (tricep area) was very sore. The patient also took paracetamol (TYLENOL) 600 mg. The outcome of the event vaccination site warmth was recovered with sequel on 29Jan2021 and recovered with sequel on Jan2021 for all other events.

Other Meds:

Current Illness:

ID: 1067960
Sex: M
Age:
State: LA

Vax Date:
Onset Date: 01/30/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data:

Allergies:

Symptoms: has been on immunotherapy for lung cancer; has been on immunotherapy for lung cancer; off-balance weakness/off-balance; off-balance weakness; feeling tired/fatigue; sleeping a lot; This is a spontaneous report from a contactable consumer (patient's wife). A male patient (husband) of an unspecified age (Age: 78, Units: Unknown) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiry date: not known), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. Medical history included the patient had been on immunotherapy for lung cancer for almost a year and it had been working and shrinking everything; took the chemo prior but stopped because of his feet as it gave him neuropathy so he only took 3; and neuropathy (he was fantastic prior to the shot with the only symptom being his feet neuropathy). Historical vaccine included first dose of BNT162B2 on an unspecified date for COVID-19 immunization (took the first dose of Pfizer COVID-19 vaccine and he was fine). The reported stated after the patient's second dose (unspecified date), he was feeling tired and sleeping a lot since this past Saturday (30Jan2021). Upon recent follow-up, the reporter asked if how long side effects last and if anyone had a reoccurrence of symptoms. The reporter was calling regarding her husband who had the second dose of vaccine and the patient had symptoms: fatigue and tiredness and it went away in a day and a half, but then he had a reoccurrence, after 2-3 days. On 04Feb2021, the patient had off-balance weakness. Yesterday morning (04Feb2021), he got up and was really off-balance. The nurse said it should subside in 1-2 days, and it did but then he had a reoccurrence. She stated he had been on immunotherapy for lung cancer for almost a year and it had been working and shrinking everything. The patient received the vaccine at (name) in (state name). The caller asked if there was an interaction with the immunotherapy and the vaccine. And also, asked if the patient should have not gotten the vaccine. She stated she will call the doctor after the call. The caller stated at the nursing home, not one person had a reaction with the second shot. The outcome of the events feeling tired/fatigue, sleeping a lot, and "off balance weakness" was not recovered. Information about Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 1067961
Sex: F
Age:
State: OH

Vax Date: 01/28/2021
Onset Date: 01/29/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data: Test Date: 20210129; Test Name: Body temperature; Result Unstructured Data: Test Result:elevated

Allergies:

Symptoms: diarrhea; injection site pain; tiredness; headache; muscle pain; chills with elevated temp; chills with elevated temp; joint pain; injection site swelling and redness; injection site swelling and redness; nausea; feeling unwell; This is a spontaneous report from a contactable consumer (patient). An 83-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL9265), via an unspecified route of administration at the left arm on 28Jan2021 at 08:00 AM (at age of 83 years old) at a single dose for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The facility where the most recent COVID-19 vaccine was administered was reported as "Other". The patient's medical history included stage 3 kidney, prediabetes, and allergies to sulfa. The patient was not diagnosed with COVID-19 prior to vaccination. The patient received unspecified concomitant medications (patient received other medications within 2 weeks of vaccination). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took hypromellose (GENTEAL; reported as "gen-teal") and experienced allergy. On 29Jan2021 at 02:00 AM, the patient experienced diarrhea, injection site pain, tiredness, headache, muscle pain, chills with elevated temp, joint pain, injection site swelling and redness, nausea, and feeling unwell. The patient did not receive treatment for the events. The patient has not been tested for COVID-19 since the vaccination. The events were reported as non-serious. The outcome of the events was recovering.

Other Meds:

Current Illness:

ID: 1067962
Sex: M
Age:
State: NV

Vax Date: 01/27/2021
Onset Date: 01/29/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Sore throat; chills; headache; lower back pain; muscle pain; sinus drainage; severe cough; This is a spontaneous report from a contactable consumer (patient). A 64-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number:EL9262), via an unspecified route of administration on the right arm on 27Jan2021 09:30 at a single dose for COVID-19 immunisation. Medical history included hypertension. The patient has no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included losartan, atenolol, and atorvastatin. The patient experienced sore throat, chills, headache, lower back pain, muscle pain, severe cough with thick yellow phlegm on 29Jan2021 13:00. It was reported that the patient had sinus drainage on 29Jan2021 13:00. There was no treatment for the events. The patient has not recovered from the events yet.

Other Meds: LOSARTAN; ATENOLOL; ATORVASTATIN

Current Illness:

ID: 1067963
Sex: F
Age:
State: PA

Vax Date: 01/21/2021
Onset Date: 01/28/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Lip tingling/fizzing; This is a spontaneous report from a contactable nurse (patient). A 42-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL 3246), via an unspecified route of administration (at the age of 42-years-old) on 21Jan2021 10:00 at a single dose in right arm for COVID-19 immunization. Medical history included none. No allergies to medications, food, or other products. Concomitant medication included rosuvastatin calcium (CRESTOR), spironolactone, tacrolimus, and macrogol 3350 (MIRALAX). The patient experienced lip tingling/fizzing on 28Jan2021 19:00 with outcome of recovering. No treatment received for the adverse event. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Facility where the most recent COVID-19 vaccine was administered was Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The event was considered as non-serious.

Other Meds: CRESTOR; SPIRONOLACTONE; TACROLIMUS; MIRALAX

Current Illness:

ID: 1067964
Sex: F
Age:
State: MD

Vax Date: 01/30/2021
Onset Date: 01/01/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data:

Allergies:

Symptoms: injection site/arm soreness/just the area around the needle site/Just tender; This is a spontaneous report received from a Pfizer-sponsored program, Pfizer First Connect. A contactable consumer (reported for herself) reported that a female patient of an unspecified age (age: 82; unit: unknown) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiry date: not known), via an unspecified route of administration on 30Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date in Jan2021, the patient mentioned "injection site/arm soreness". The patient said it was just the area around the needle site. Just tender. It was not extremely sire, it was tender sore. The patient was asking if how she would know if they will get a hematoma after the vaccine and if she should expect anything and the patient was made aware of signs of potential hematoma with redness, swelling, pain or bruising. The patient was referred to speak with healthcare professional (HCP) if she believes there is a hematoma or concerns about potential hematoma forming. The outcome of the event was unknown. Information on the Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 1067965
Sex: M
Age:
State: CA

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data:

Allergies:

Symptoms: the onset of blurred vision in one eye and flashing colored lights in both eyes.; the onset of blurred vision in one eye and flashing colored lights in both eyes.; This is a spontaneous report from a contactable physician (patient). A 78-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9262), intramuscular at the left arm on 21Jan2021 08:45 at single dose for COVID-19 immunization. Medical history included Parkinson's and neuropathy. The patient has allergies to CIPRO antibiotics. Concomitant medication included unspecified multiple supplements. On 22Jan2021 at 09:00 (24 hours after vaccination), the patient had the onset of blurred vision in one eye and flashing colored lights in both eyes. This was unlike anything he has ever experienced, and it persisted for several hours. Vision gradually returned to normal and lights disappeared. This was not a retinal detachment or vitreous detachment. It was not associated with eye pain. The patient did not receive any treatment for the events. The patient recovered from the events on an unspecified date in 2021.

Other Meds:

Current Illness:

ID: 1067966
Sex: F
Age:
State: WI

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data:

Allergies:

Symptoms: just a sore arm starting approx 6 hours after injection; This is a spontaneous report from a contactable healthcare professional (patient). A 51-year-old non-pregnant female patient received her first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: EL3249; expiration date: unknown) at vaccination age of 51-year-old intramuscular in the right arm on 15Jan2021 10:00 at a single dose for covid-19 immunization. Medical history included high blood pressure, and allergies to penicillin and sulfa. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included unspecified medication. The patient received her most recent COVID-19 in a public health clinic/veterans administration facility. The patient reported that she did no adverse events, she was just a sore arm starting approximately 6 hours after injection (15Jan2021) and lasting about 24 hours (16Jan2021). The event was non-serious. The patient has not been tested for COVID-19 since the vaccination. The outcome of the event was recovered on 16Jan2021. No follow up attempts are possible. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1067967
Sex: M
Age:
State: FL

Vax Date: 01/25/2021
Onset Date: 01/25/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Face flush for 6 hours; This is a spontaneous report from a non-contactable consumer. A 67-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) first dose, lot number and expiration date unknown, via an unspecified route of administration at the age of 67 years on 25Jan2021 11:30 at single dose in the left arm for COVID-19 immunization. Medical history included mild hypertension. The patient had no allergies to medications, food, or other products. Prior vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included rosuvastatin, losartan and hctz. The patient experienced face flush (non-serious) for 6 hours on 25Jan2021 11:45. There was no treatment for the events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient has not been tested for COVID-19 since vaccination. The outcome of the event was recovered. No follow-up attempts are possible, information about batch number cannot be obtained.

Other Meds: ROSUVASTATIN; LOSARTAN; HCTZ

Current Illness:

ID: 1067968
Sex: M
Age:
State: HI

Vax Date: 01/30/2021
Onset Date: 01/31/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data: Test Date: 20210106; Test Name: COVID-19 RT-PCR; Test Result: Negative ; Comments: Nasal Swab, reported as post-vaccination.

Allergies:

Symptoms: Headache; Pain at injection site; Swollen injection site; Fatigued; This is a spontaneous report from a contactable consumer (patient). A 30 -year-old male patient received his first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EL9626), via an unspecified route of administration (on the left arm) on 30Jan2021 16:15 (at the age of 30-years-old), single dose for COVID-19 immunization. The patient's medical history was not reported. Concomitant medication included amlodipine;olmesartan, lorazepam. The patient experienced Headache,Pain at injection site, Swollen injection site, Fatigued, all on 31Jan2021. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 06Jan2021 Nasal Swab (reported as post vaccination). No treatment received for the adverse events. The outcome of the events was not recovered. Prior to vaccination, it is unknown if the patient diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19 (date of test reported as 06Jan2021). The reporter assessed the events as non-serious.

Other Meds: AMLODIPINE;OLMESARTAN; LORAZEPAM

Current Illness:

ID: 1067969
Sex: F
Age:
State: NJ

Vax Date: 01/26/2021
Onset Date: 01/31/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fever; This is a spontaneous report from a contactable consumer (patient herself). A 47-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EL 9262, expiration date was unknown), via an unspecified route of administration on 26Jan2021 at 08:30 AM at a single dose for COVID-19 immunization. The facility where the most recent COVID-19 vaccine was administered was reported as the hospital. The patient's medical history was not reported. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Jan2021 at 11:00 AM, the patient experienced fever. The patient assessed the event as non-serious. The patient did not receive any treatment for the adverse event. The patient was not recovered from the event.

Other Meds:

Current Illness:

ID: 1067970
Sex: M
Age:
State: CA

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data: Test Date: 20210125; Test Name: COVID-19 Nasal RT-PCR; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptoms: sciatic nerve diagnosed as inflamed only left leg and shot provided left arm; This is a spontaneous report from a contactable nurse (patient). A 62-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not provided) solution for injection, via an unspecified route of administration in right arm on 08Jan2021 14:00 at a single dose for Covid-19 immunization. Medical history included blood pressure. Concomitant medication included unspecified blood pressure medication. On 09Jan2021 at 2pm, sciatic nerve was diagnosed as inflamed only on left leg and shot (treatment) was provided in left arm. Patient visited emergency room/department, methylprednisolone sodium succinate (PF) was given as treatment. The event was reported as non-serious, patient was not hospitalized. The patient underwent lab tests which included COVID-19 Nasal RT-PCR: negative on 25Jan2021 (Nasal Swab). Outcome of the event was recovering. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1067971
Sex: U
Age:
State: NC

Vax Date: 01/15/2021
Onset Date: 01/17/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Right arm remains red; Sweats profusely; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received bnt162b2 (BNT162B2; Lot number and expiry date not reported) via an unspecified route of administration to right arm from 15Jan2021 at 09:00 at single dose for covid-19 immunization. Medical history included arthritis from an unknown date. There were no concomitant medications. The patient experienced Right arm remains red and sweats profusely on 17Jan2021 at 12:00 AM. The events were reported as non-serious. No treatments were received for the reported events. The outcome of the events was not recovered. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1067972
Sex: F
Age:
State: NY

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data:

Allergies:

Symptoms: the vision in my right eye became blurry; This is a spontaneous report from a contactable consumer (patient herself). A 78-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: el9262), via an unspecified route of administration in the left arm on 26Jan2021 09:00 at a single dose for COVID-19 immunization. The patient had no relevant medical history and no known allergies. Concomitant medication included metoprolol succinate (TOPROL 25 mg) received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. She previously received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: el3246), via an unspecified route of administration in the left arm on 05Jan2021 11:30 for COVID-19 immunization. The patient was not diagnosed with COVID-19 prior to vaccination. She was not pregnant. The patient experienced "the vision in my right eye became blurry" on 26Jan2021 09:15. The patient reported that the event was "still is" as date of the report. The event was reported as non-serious and resulted in doctor or other healthcare professional office/clinic visit. The outcome of the events was not recovered. The patient had not been tested for COVID-19 since the vaccination.

Other Meds: TOPROL

Current Illness:

ID: 1067973
Sex: F
Age:
State: MD

Vax Date: 01/26/2021
Onset Date: 01/30/2021
Rec V Date: 03/03/2021
Hospital:

Lab Data:

Allergies:

Symptoms: sudden rash appear on left side of my chest and shoulder, just visually a bunch of red dots; Swollen lymph nodes, both collar bone and neck; This is a spontaneous report from a contactable consumer (patient). A 30-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1283), via an unspecified route of administration at the left arm on 26Jan2021 at single dose for COVID-19 immunisation. The patient has no medical history. The patient was not pregnant at the time of vaccination. Concomitant medication included ethinylestradiol, levonorgestrel (LUTERA). The patient experienced swollen lymph nodes, both collar bone and neck noticed the evening of 30Jan2021. Expected as much for an immune response, but then she had a sudden rash appear on left side of her chest and shoulder, just visually a bunch of red dots, no itching or discomfort the afternoon of 31Jan2021. She was reporting immediately, so no recovery yet. The patient did not receive any treatment for the events. The patient has not recovered from the events.

Other Meds: LUTERA

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm